1 / 1

Supplementary Figure 3

control. control. ZVAD. ZVAD. JNK Inhibitor. JNK Inhibitor. ZVAD+JNK Inhibitor. ZVAD+JNK Inhibitor. 120. 100. 80. % Control. 60. 40. 20. 0. 0. 6.25. 12.5. 25. 50. Cerulenin μ M. U266. 120. 100. 80. % Control. 60. 40. 20. 0. 0. 6.25. 12.5. 25. 50.

emmet
Download Presentation

Supplementary Figure 3

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. control control ZVAD ZVAD JNK Inhibitor JNK Inhibitor ZVAD+JNK Inhibitor ZVAD+JNK Inhibitor 120 100 80 % Control 60 40 20 0 0 6.25 12.5 25 50 Cerulenin μM U266 120 100 80 % Control 60 40 20 0 0 6.25 12.5 25 50 Cerulenin μM A MM.1S B Supplementary Figure 3. Analysis of inhibition by JNK inhibitor SP600215 and/or ZVAD-FMK in MM cells (A) (B) MM.1S and U266 cells were cultured with indicated dose of Cerulenin for 24 hours, with or without JNK inhibitor SP600215 (10 M) and/or ZVAD-FMK (50 M) pretreatment for 1 hour. Cytotoxicity was determined by MTT assay. Values represent mean  SD of quadruplicate cultures. Although ZVAD-FMK does not affect cytotoxicity by Cerulenin, JNK inhibitor significantly blocks Cerulenin-induced cytotoxicity (P<0.05). Supplementary Figure 3

More Related